Yuhan Corp. announced that it has entered into a memorandum of understanding (MOU) with the Daegu‑Gyeongbuk Advanced Medical Industry Promotion Foundation, known as K‑MediHub. The agreement aims to strengthen Yuhan's innovative new‑drug pipeline by leveraging K‑MediHub's research infrastructure and technical support system.
Under the MOU, the two parties will collaborate on discovering and executing joint new‑drug research projects, exchange research personnel to enhance R&D capabilities, and share access to research facilities and advanced equipment.
The partnership is intended to expand opportunities for co‑development of promising drug candidates, combining Yuhan's development expertise with K‑MediHub's resources.
Research & ReportsSep 14, 2026•3 min read
Yuhan Corp. and K-MediHub Sign MOU to Expand Joint New Drug Research
Yuhan Corp. has signed an MOU with Daegu‑Gyeongbuk Advanced Medical Industry Promotion Foundation (K‑MediHub) to broaden joint new‑drug projects and share research infrastructure.
Compiled by the Pharmacountry team · Source: KPA News
Topics:
Ratings
(0)
(0)
(0)
(0)
(0)
Leave your rating